Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.03 | 1.66 |
NAV | ₹15.44 | ₹309.90 |
Fund Started | 04 Mar 2022 | 06 Jan 1994 |
Fund Size | ₹104.91 Cr | ₹23898.61 Cr |
Exit Load | Exit load of 1% if redeemed within 15 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.28% | 9.84% |
3 Year | - | 16.88% |
5 Year | - | 21.35% |
1 Year
3 Year
5 Year
Equity | 100.19% | 98.69% |
Cash | -0.19% | 1.30% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 4.25% |
ICICI Bank Ltd. | 4.02% |
Page Industries Ltd. | 3.94% |
Dr. Reddy's Laboratories Ltd. | 3.94% |
HDFC Bank Ltd. | 3.82% |
ITC Ltd. | 3.79% |
Apollo Hospitals Enterprise Ltd. | 3.64% |
Bharti Airtel Ltd. | 3.63% |
MRF Ltd. | 3.54% |
Abbott India Ltd. | 3.49% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.07% |
ICICI Bank Ltd. | 3.70% |
Infosys Ltd. | 2.62% |
Axis Bank Ltd. | 1.89% |
Mphasis Ltd. | 1.83% |
Indusind Bank Ltd. | 1.51% |
Lupin Ltd. | 1.50% |
Tata Consultancy Services Ltd. | 1.44% |
Bharti Airtel Ltd. | 1.42% |
State Bank of India | 1.40% |
Name | Swapnil P Mayekar | Gopal Agrawal |
Start Date | 14 Jul 2022 | 29 Jul 2022 |
Name
Start Date
Description | The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by S&P BSE Low Volatility Total Return Index, subject to tracking error. | The scheme seeks to generate long term capital appreciation/income from a portfolio, predominantly invested in equity and equity related instruments. |
Launch Date | 04 Mar 2022 | 06 Jan 1994 |
Description
Launch Date